When the U.S. Drug Supply Chain Security Act was ratified, it established new requirements for the exchange of serialized T2 data at each step of the supply chain. However, there are several unique shipment scenarios that can complicate the exchange of the necessary compliance data. This can disrupt shipment and receiving processes, even leading to costly delays.
We caught up with Dan Walles, Global Manager of Traceability & Compliance at TraceLink, to discuss how the Enhanced Drug Distribution Security (EDDS) requirements of the DSCSA impact shipments and what you need to do to handle these scenarios.
How does the DSCSA impact shipments?
Under the DSCSA, serialized T2 data must be sent to the recipient along with the physical product before the product can be sold or shipped further down the supply chain. Read more >
TraceLink’s network platform, with Integrate Once, Interoperate with Everyone™ capability, revolutionizes compliance and operational efficiency for dispensing customers. By seamlessly connecting with an expansive digital network of supply chain partners, TraceLink ensures robust compliance with the Drug Supply Chain Security Act (DSCSA), swiftly manages compliance exceptions, and enables streamlined digital recalls. Furthermore, its advanced analytics capabilities facilitate the prediction of drug shortages, enhancing supply chain resilience. This integration offers pharmacies, hospitals, and other dispensers a comprehensive solution that not only meets regulatory demands but also optimizes inventory management and maintains the integrity of the drug supply, ensuring patient safety and continuity of care.
